119 related articles for article (PubMed ID: 36890037)
1. Brain Metastasis Growth Kinetics: A Novel Prognosticator for Stereotactic Radiotherapy.
Lee SF; Yip PL; Chan OL; Lee VWY; Wong A; Choi HCW
Clin Oncol (R Coll Radiol); 2023 May; 35(5):e328-e335. PubMed ID: 36890037
[TBL] [Abstract][Full Text] [Related]
2. Radiological Kinetics of Brain Metastases and Clinical Implications for Patients Treated With Stereotactic Radiosurgery.
Nicholls LW; Pinkham MB; Bernard A; Lusk R; Watkins T; Hall B; Olson S; Foote MC
Clin Oncol (R Coll Radiol); 2019 Jan; 31(1):34-40. PubMed ID: 30279038
[TBL] [Abstract][Full Text] [Related]
3. Radiosurgery for brain metastases: a score index for predicting prognosis.
Weltman E; Salvajoli JV; Brandt RA; de Morais Hanriot R; Prisco FE; Cruz JC; de Oliveira Borges SR; Wajsbrot DB
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1155-61. PubMed ID: 10725626
[TBL] [Abstract][Full Text] [Related]
4. Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
Tuleasca C; Negretti L; Faouzi M; Magaddino V; Gevaert T; von Elm E; Levivier M
J Neurosurg; 2018 Feb; 128(2):352-361. PubMed ID: 28338441
[TBL] [Abstract][Full Text] [Related]
5. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
[TBL] [Abstract][Full Text] [Related]
6. Frameless stereotactic radiosurgery for brain metastases: a review of outcomes and prognostic scores evaluation.
Mok ST; Kam MK; Tsang WK; Poon DM; Loong HH; Yeung WM; Yeung TY; Yu J; Wong CK
Hong Kong Med J; 2017 Dec; 23(6):599-608. PubMed ID: 29125123
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
Hirata M; Yasui K; Oota N; Ogawa H; Onoe T; Maki S; Ito Y; Hayashi K; Asakura H; Murayama S; Mitsuya K; Deguchi S; Nakamura K; Hayashi N; Nishimura T; Harada H
Radiat Oncol; 2022 Dec; 17(1):213. PubMed ID: 36578021
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of salvage stereotactic radiotherapy (SRT) for locally recurrent brain metastases after initial SRT and characteristics of target population.
Holub K; Louvel G
Clin Transl Oncol; 2021 Jul; 23(7):1463-1473. PubMed ID: 33464481
[TBL] [Abstract][Full Text] [Related]
9. Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Thiery A; Cebula H; Noel G; Antoni D
Radiat Oncol; 2023 Jan; 18(1):21. PubMed ID: 36717863
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of stereotactic radiotherapy for metastases from renal cell carcinoma.
Majewski W; Tabor M; Banaszek P; Glowacki G; Rokicki W; Tukiendorf A
Neoplasma; 2016; 63(1):99-106. PubMed ID: 26639239
[TBL] [Abstract][Full Text] [Related]
11. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
12. Cumulative intracranial tumour volume prognostic assessment: a new predicting score index for patients with brain metastases treated by stereotactic radiosurgery.
Donofrio CA; Cavalli A; Gemma M; Riccio L; Donofrio A; Panni P; Ferrari da Passano C; Del Vecchio A; Bolognesi A; Soffietti R; Mortini P
Clin Exp Metastasis; 2020 Aug; 37(4):499-508. PubMed ID: 32430649
[TBL] [Abstract][Full Text] [Related]
13. Comparison of WBRT alone, SRS alone, and their combination in the treatment of one or more brain metastases: Review and meta-analysis.
Khan M; Lin J; Liao G; Li R; Wang B; Xie G; Zheng J; Yuan Y
Tumour Biol; 2017 Jul; 39(7):1010428317702903. PubMed ID: 28675121
[TBL] [Abstract][Full Text] [Related]
14. Radionecrosis after repeated courses of radiotherapy under stereotactic conditions for brain metastases: Analysis of clinical and dosimetric data from a retrospective cohort of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Cox DG; Bund C; Antoni D; Cebula H; Noel G
Cancer Radiother; 2022 Sep; 26(5):692-702. PubMed ID: 35715354
[TBL] [Abstract][Full Text] [Related]
15. Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain Metastasis.
Lamba N; Cagney DN; Brigell RH; Martin AM; Besse LA; Catalano PJ; Phillips JG; Pashtan IM; Bi WL; Claus EB; Golby AJ; Dunn IF; Smith TR; Tanguturi SK; Haas-Kogan DA; Alexander BM; Aizer AA
World Neurosurg; 2019 Feb; 122():e1557-e1561. PubMed ID: 30471438
[TBL] [Abstract][Full Text] [Related]
16. A new prognostic model for brain metastases of specific primary tumors with stereotactic radiotherapy.
Gu L; Qing S; Zhang HJ
Cancer Radiother; 2023 May; 27(3):183-188. PubMed ID: 36781369
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of X-ray stereotactic radiotherapy on brain metastases and prognostic analysis.
Wei W; Deng ML; Wu SX; Zeng ZF; Li FY; Wang HY; Bao Y; Gao YH; Chen LX
Chin J Cancer; 2010 Feb; 29(2):202-6. PubMed ID: 20109352
[TBL] [Abstract][Full Text] [Related]
18. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
[TBL] [Abstract][Full Text] [Related]
19. Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
Badakhshi H; Engeling F; Budach V; Ghadjar P; Zschaeck S; Kaul D
Radiat Oncol; 2018 Jan; 13(1):3. PubMed ID: 29316943
[TBL] [Abstract][Full Text] [Related]
20. Discovery of additional brain metastases on the day of stereotactic radiosurgery: risk factors and outcomes.
Garcia MA; Lazar A; Duriseti S; Raleigh DR; Hess CP; Fogh SE; Barani IJ; Nakamura JL; Larson DA; Theodosopoulos P; McDermott M; Sneed PK; Braunstein S
J Neurosurg; 2017 Jun; 126(6):1756-1763. PubMed ID: 27367235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
